The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Clinical and Demographic Predictors of Outcomes in Recent Onset Dilated Cardiomyopathy
Open accessAbstract
Objective We sought to determine clinical and demographic predictors of recovery of left ventricular function for subjects with recent onset cardiomyopathy (ROCM). Background While ROCM is a frequent reason for consultation and transplant referral, its prognosis and natural history on contemporary therapy are unknown. Methods In the multicenter Intervention in Myocarditis and Acute Cardiomyopathy (IMAC2) study, subjects with a LVEF ≤ 0.40, less than six months of symptoms and an evaluation consistent with idiopathic dilated cardiomyopathy or myocarditis were enrolled, LVEF reassessed at six months, and subjects followed for 4 years. LVEF and event free survival were compared by race, gender, and clinical phenotype. Results The cohort of 373 was 38% female, 21% black, with a mean age of 45 ± 14 years. At entry, 91% were receiving ACE inhibitors or ARBs and 82% beta blockers, which increased to 92% and 94% at 6 months. LVEF was 0.24 ± 0.08 at entry and 0.40±0.12 at six months (mean increase 17± 13 EF units). Transplant-free survival at 1, 2 and 4 years was 94, 92 and 88%; survival-free of heart failure hospitalization was 88, 82 and 78%. In analyses adjusted for gender, baseline LVEF, and blood pressure, LVEF at six months was significantly lower in blacks than in non-blacks (p=0.02). LVEDD at presentation was the strongest predictor of LVEF at 6 months (p<0.0001). Conclusion Outcomes in recent onset dilated cardiomyopathy are favorable but differ by race. LVEDD by transthoracic echo at presentation was most predictive of subsequent myocardial recovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Clinical Trial of Immunosuppressive Therapy for Myocarditis
Mason, J. W., O'Connell, J. B., Herskowitz, A., Rose, N. R., McManus, B. M., Billingham, M. E., & Moon, T. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508033330501 · Cited by 1,274
Cooper, L. T., Baughman, K. L., Feldman, A. M., Frustaci, A., Jessup, M., Kuhl, U., Levine, G. N., Narula, J., Starling, R. C., Towbin, J., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.186093 · Cited by 1,030
Self-citation
Cited by
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8776 · Cited by 2,106
Myocarditis and inflammatory cardiomyopathy: current evidence and future directions
Tschöpe, C., Ammirati, E., Bozkurt, B., Caforio, A. L. P., Cooper, L. T., Felix, S. B., Hare, J. M., Heidecker, B., Heymans, S., Hübner, N., et al. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00435-x · Cited by 1,217
Self-citationSagar, S., Liu, P. P., & Cooper, L. T. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60648-x · Cited by 743
Self-citationSchultheiss, H.-P., Fairweather, D., Caforio, A. L. P., Escher, F., Hershberger, R. E., Lipshultz, S. E., Liu, P. P., Matsumori, A., Mazzanti, A., McMurray, J., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0084-1 · Cited by 720
Metadata
- Authors
- McNamara, D. M., Starling, R. C., Cooper, L. T., Boehmer, J. P., Mather, P. J., Janosko, K. M., Gorcsan, J., Kip, K. E., & Dec, G. W.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 58
- Issue
- 11
- Pages
- 1112-1118
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2169710365
- Cited by
- 242
- References
- 2
- FWCI
- 12.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical and Demographic Predictors of Outcomes in Recent Onset Dilated Cardiomyopathy. https://app.cochat.ai/papers/10.1016/j.jacc.2011.05.033
- The paper
- McNamara, D. M., Starling, R. C., Cooper, L. T., Boehmer, J. P., Mather, P. J., Janosko, K. M., Gorcsan, J., Kip, K. E., & Dec, G. W. (2011). Clinical and Demographic Predictors of Outcomes in Recent Onset Dilated Cardiomyopathy. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2011.05.033
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.